In order to ensure the scientific and impartial nature of drug evaluation and fully leverage the role of external experts in the drug review process, and in accordance with the Measures for the Management of External Experts of the Center for Drug Evaluation, the Center for Drug Evaluation has organized and carried out the reappointment of external experts. External experts submitted reappointment applications to the Center based on factors such as personal willingness, age, and conflicts of interest. After review by the Center in accordance with established procedures, the External Expert Reappointment List of the Center for Drug Evaluation (2026 First Batch) (Draft for Comments) has been formulated.
The External Expert Reappointment List of the Center for Drug Evaluation (2026 First Batch) (Draft for Comments) is hereby released for public consultation. The consultation period runs from August 14 to August 24. During the consultation period, if any objections to the above experts arise, they may be reported to our Center with real-name identification.
Contact Persons: Zhang Fan, Tian Yi
Contact Email: yewuguanlichu@cde.org.cn
Annex: External Expert Reappointment List of the Center for Drug Evaluation (2026 First Batch) (Draft for Comments)
Center for Drug Evaluation, National Medical Products Administration
August 13, 2026
Source: Center for Drug Evaluation, National Medical Products Administration
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.
